7T MR excels in MS detection
Armed with better signal-to-noise ratios and advantageous relaxation values, 7T MR imaging enables much better visualization of the most common type of multiple sclerosis lesions and could pave the way for earlier detection of the disease, according to research from Ohio State University.
Armed with better signal-to-noise ratios and advantageous relaxation values, 7T MR imaging enables much better visualization of the most common type of multiple sclerosis lesions and could pave the way for earlier detection of the disease, according to research from Ohio State University.
In making earlier diagnosis possible, 7T MR could one day expand therapeutic options and help halt disease progression, according to Dr. Steffen Sammett, a research scientist.
Sammett demonstrated the value of 3T and 7T in visualizing MS lesions in a postmortem formalin-fixed brain in an exhibit at the 2007 American Roentgen Ray Society meeting. All images were taken on the whole-body Achieva unit from Philips Medical Systems.
Brain and spinal imaging are now typically performed on 1.5T MR units. Sammett's research showed that both 3T and 7T imaging allowed better visualization of the common cortical lesions, which often are missed with conventional MR. Furthermore, many lesions were seen on 7T but not on 3T images.
Spin-echo images taken on 3T and 7T units also allowed visualization of cortical MS plaques. Again, the best visualization occurred at 7T.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
